Toripalimab With Preoperative Chemoradiotherapy for LA-EGJ
NCT04061928
·
clinicaltrials.gov ↗
PHASE1,PHASE2
Phase
UNKNOWN
Status
45
Enrollment
OTHER
Sponsor class
Conditions
PD-1
Chemoradiotherapy
Gastroesophageal Junction Cancer
Interventions
DRUG:
PD-1
Sponsor
Peking University